In accordance with the proinflammatory CDK signaling, p16INK4A protein as a Cyclin-Dependent Kinases inhibitor in synovial fibroblasts also demonstrated an inhibitory action in the development of RA [40]. Here, CDKN2A is linked to rheumatoid arthritis.